Compound pharmaceutic preparation for treating pneumoconiosis

Abstract

The invention discloses a compound pharmaceutic preparation for treating pneumoconiosis. The preparation is prepared from raw materials in parts by weight as follows: 35-45 parts of white peony roots, 25-35 parts of stir-fried perilla fruits, 35-45 parts of seabuckthorn fruits, 15-25 parts of semen caesalpiniae cristae, 25-35 parts of small centipeda herbs, 25-35 parts of platycodon roots, 25-35 parts of immature orange fruits, 15-25 parts of shortstalk monkshood roots, 25-35 parts of fragrant solomonseal rhizomes, 25-35 parts of honeysuckle flowers, 35-45 parts of Caragana sinica, 5-15 parts of roselle calyx, 15-25 parts of cherokee rose fruits and 25-35 parts of mix-fried licorice roots. During treatment, the preparation is taken orally three times a day, and 3-5 granules are taken each time. The compound pharmaceutic preparation for treating the pneumoconiosis has effects of clearing lung-heat, moistening dryness, eliminating phlegm, promoting blood circulation, supplementing qi, nourishing yin and the like, can improve multiple symptoms such as coughs and asthma, chest stifling, expectorating, susceptibility to colds, easily associated latent nephrosis and the like which are caused by the pneumoconiosis, and has the advantages of good treatment effect, low cost and the like.

Description

technical field [0001] The invention relates to a compound medicinal preparation for treating pneumoconiosis. Background technique [0002] Pneumoconiosis is caused by long-term inhalation of productive dust (such as coal powder, mineral powder, welding dust, etc.) growth, and then destroy the normal lung tissue, reduce the elasticity of the lung, and affect the normal respiratory function of the lung. Because pneumoconiosis has no specific clinical manifestations, early silicosis has no obvious symptoms or only mild symptoms, which are often only found during examination, but when the disease is further developed, when it is discovered, especially in advanced patients, There will be mild or severe subjective symptoms based on the respiratory system. The first symptom is cough, sputum, hemoptysis, chest tightness, chest pain, shortness of breath, weight loss, weakness, insomnia, loss of appetite, etc. A small number of patients with tuberculosis, when the condition is mild ...

AI Technical Summary

Problems solved by technology

[0005] The current method of treating pneumoconiosis is large-volume lung lavage therapy, which is a new technology developed in the past 20 years. Because it can remove part of the dust in the lungs, improve symptoms and lung function, and improve the quality of life of patients, it is welcomed by the majority of patients. But the expenditure of tens of thousands of yuan each time has become a burden for patients